Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.
about
White Blood Cells, Neutrophils, and Reactive Oxygen Metabolites among Asymptomatic SubjectsIs leukocytosis a predictor for recurrence of ischemic events after coronary artery bypass graft surgery? A cohort study.Making a difference: monocyte heterogeneity in cardiovascular diseaseRed cell distribution width and neutrophil-to-lymphocyte ratio predict left ventricular dysfunction in acute anterior ST-segment elevation myocardial infarctionWhite blood cell count and mortality in the Baltimore Longitudinal Study of AgingLeukocytosis as a predictor for non-infective mortality and morbidity.White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction.White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease.Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.Impact of Neutrophil to Lymphocyte Ratio (NLR) Index and Its Periprocedural Change (NLRΔ) for Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion.Could neutrophil/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow?Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis?Prognostic Value of the Neutrophil-Lymphocyte Ratio in Patients With ST-Elevated Acute Myocardial Infarction.Impact of white blood cell count on myocardial salvage, infarct size, and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a magnetic resonance imaging study.Relationship between neutrophil-to-lymphocyte ratio and saphenous vein graft disease in patients with coronary bypass.White blood count and infarct size, myocardial salvage and clinical outcomes: the role of differentials.Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction.Severity of coronary atherosclerosis is an independent predictor of the left ventricular ejection fraction.Relation of neutrophil-to-lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-segment elevated myocardial infarction.Immunological aspects of atherosclerosis: Figure 1
P2860
Q36075350-49A814AA-7B93-4C6A-A21E-BC64F0ABF60AQ36090405-359991FA-DD08-4356-9C48-CB4CF6614ABBQ36218472-4F1A877D-CA87-4D90-98C5-34047DB21FE8Q37030253-01622770-C05E-48A9-9D26-EDC687E17F75Q37105410-C03DC8A5-7E42-400E-8A27-1D44CC3B039DQ37670502-DC51D54C-D212-4A21-9FF7-B6FC9F2F894DQ37710353-F3E17894-B340-48B0-B24A-F30E423D4CCFQ38207471-F850E625-AA7F-46D5-9F94-157FFC7AE39FQ39619295-89FBF7DA-4629-4CC0-97BB-2F36BEDBF7BCQ39747865-9B46DF1B-C8BE-4663-B65B-C6412DD6F3B1Q42340246-871CE037-9D84-49F1-B167-93BFEBDD5BA6Q42469005-A84EF6E2-40CB-4977-82EC-E3DFA64A3BEAQ43759675-FBEECBCD-0296-4BF8-889E-7FAAB612A8D9Q45077442-FBFC94FF-69E8-47EC-B474-530CBDA41108Q46833779-053F7612-D94E-4659-B56F-9DE52E1210D9Q47191116-3F9CB56B-EACC-4302-904E-4D1B8C948AAFQ51065281-4ADCCC9D-B5D4-40AB-9FBA-9E7AA5A24075Q51325065-10FB7326-BB15-4DAA-ABD9-A2444694A4B1Q51382935-07FEFF52-BC3E-4D7D-B565-0199332A370CQ53088524-46D820C1-E5AC-4181-BB92-2E0BE9B951DCQ57132246-DD1039D8-A4F6-4100-8364-3D413BC468C8
P2860
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@ast
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@en
type
label
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@ast
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@en
prefLabel
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@ast
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@en
P2093
P2860
P356
P1433
P1476
Impact of preprocedural white ...... , EPILOG, and EPISTENT trials.
@en
P2093
P2860
P304
P356
10.1136/HEART.89.10.1200
P407
P577
2003-10-01T00:00:00Z